BioSpace News Archive

Oncorus, Inc., a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies to transform outcomes for cancer patients, today announced the pricing of its initial public offering of 5,800,000 shares of common stock at a price to the public of $15.00 per share.

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today that the US Food and Drug Administration (FDA) has issued a Complete Response Letter to its Biologics License Application (BLA) for remestemcel-L for the treatment of pediatric steroid-refractory acute graft versus host disease (SR-aGVHD).

Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced that it has priced its underwritten public offering (the “Offering”) of 8,475,000 shares of its common stock at a price of $20.50 per share.

“Pharmaceutical and medical device industries are increasingly turning to more sustainable test methods for the accurate detection of pyrogenic contamination. In response to these market trends, we are very excited to expand our portfolio of sustainable testing solutions with the PyroCell™ MAT System, which will better support the customer’s needs during development and ensure product safety.”

Colorado BioScience Association (CBSA) brings leaders from Colorado life sciences companies and organizations together this week for the highly anticipated Colorado Life Sciences Innovation Forum and Trade Show . The event features national and Colorado thought leaders highlighting the most pressing and relevant topics for Colorado’s health inno

PAO Group, Inc. (USOTC: PAOG) today announced engaging Saul Kaye the founder of iCAN ( www.israel-cannabis.com ) and CannaTech ( www.canna-tech.co ) to provide an independent review of PAOG’s RespRx research for the treatment of Chronic Obstructive Pulmonary Disease (COPD), and to help prepare RexpRx for engaging with a contra

YourEncore, a strategic consultancy specializing in Quality, Regulatory, and Clinical challenges in the Life Sciences industry, today announced that the firm has expanded their Quality and Compliance portfolio to include a new Quality Management System (QMS) solution designed specifically to meet the unique needs of growing biopharmaceutical companies.

General Dynamics Information Technology (GDIT), a business unit of General Dynamics (NYSE: GD), announced today it was awarded the File Conversion Services task order under the Veterans Intake, Conversion, and Communication Services (VICCS) program by the Department of Veterans Affairs (VA) Veterans Benefit Administration (VBA).

The Required Use of Face Masks Tied to the Ongoing COVID-19 Pandemic Have Provided Challenges for Those With Hearing Loss. Learn Easy Ways You Can Help.

DetectaChem, the global leader in innovative portable threat detection technologies used daily by U.S. Homeland Security, Department of Defense and first responder agencies around the world, announces their MobileDetect Bio BCC19 COVID-19 tests are being successfully deployed by prestigious colleges and universities in the U.S. to help support a safe return to campus for students and staff.